SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-115329
Filing Date
2023-11-07
Accepted
2023-11-07 17:14:35
Documents
1
Period of Report
2023-10-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2329765-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2329765-1_3seq1.xml 3 5715
  Complete submission text file 0001104659-23-115329.txt   7920
Mailing Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070
Business Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070 9732354295
ROCHE HOLDING LTD (Reporting) CIK: 0000889131 (see all company filings)

State of Incorp.: V8
Type: 3 | Act: 34 | File No.: 001-39617 | Film No.: 231385079
SIC: 8880 American Depositary Receipts

Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Reporting) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: 3 | Act: 34 | File No.: 001-39617 | Film No.: 231385078

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Issuer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)